OpenBilldrug price receipt

NADAC week of 2026-10-14

PYRAZINAMIDE 500 MG TABLET

For 30 tablets

Pharmacies pay

$39.24 filed

30 × $1.30807 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$95.08 filed

30 × $3.16939 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.4× estimated

Medicare paid 2.4× what pharmacies pay.

Part D averages every strength and form sold under “Pyrazinamide” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$50.13 estimated

$39.24 + $5.89 (15%) + $5.00 fee per fill = $50.13

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

PYRAZINAMIDE 500 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as pyrazinamide.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc, Macleods Pharmaceuticals Limited and American Health Packaging.

FDA’s Established Pharmacologic Class for it is Antimycobacterial.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 10 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $39.24 for 30 tablets (30 × $1.30807 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 4 labelers

LabelerNDCsPharmacies pay per unit
Hikma Pharmaceuticals USA Inc4$1.30807 per EA filed
ANI Pharmaceuticals, Inc.3$1.30807 per EA filed
Macleods Pharmaceuticals Limited2$1.30807 per EA filed
American Health Packaging1$1.30807 per EA filed
Not listed as a package in the FDA directory1$1.30807 per EA filed
All 11 NDCs, with labeler and price
  • 00054-0812-21 · Hikma Pharmaceuticals USA Inc · $1.30807 per EA · eff. 2026-09-23 filed
  • 00054-0812-22 · Hikma Pharmaceuticals USA Inc · $1.30807 per EA · eff. 2026-09-23 filed
  • 00054-0812-25 · Hikma Pharmaceuticals USA Inc · $1.30807 per EA · eff. 2026-09-23 filed
  • 00054-0812-29 · Hikma Pharmaceuticals USA Inc · $1.30807 per EA · eff. 2026-09-23 filed
  • 33342-0447-11 · Macleods Pharmaceuticals Limited · $1.30807 per EA · eff. 2026-09-23 filed
  • 33342-0447-15 · Macleods Pharmaceuticals Limited · $1.30807 per EA · eff. 2026-09-23 filed
  • 60687-0789-01 · American Health Packaging · $1.30807 per EA · eff. 2026-09-23 filed
  • 60687-0789-11 · not listed as a package in the FDA directory · $1.30807 per EA · eff. 2026-09-23 filed
  • 70954-0484-10 · ANI Pharmaceuticals, Inc. · $1.30807 per EA · eff. 2026-09-23 filed
  • 70954-0484-20 · ANI Pharmaceuticals, Inc. · $1.30807 per EA · eff. 2026-09-23 filed
  • 70954-0484-30 · ANI Pharmaceuticals, Inc. · $1.30807 per EA · eff. 2026-09-23 filed

Compared with its class

The middle of its 11 NDCs’ NADAC prices is $1.30807 per EA filed.

Of the 4 other products in FDA’s Antimycobacterial class priced per EA, 2 have a higher middle NADAC price and 2 a lower one. The one in the middle is ETHAMBUTOL HCL 400 MG TABLET, at $0.458 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $95.08 for 30 tablets, at an average of $3.16939 per EA in 2024 (2024-01-01 to 2024-12-31) for “Pyrazinamide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 2,444 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for PYRAZINAMIDE 500 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Pyrazinamide / Pyrazinamide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.